Comorbidity Burden and Adverse Outcomes After Transcatheter Aortic Valve Replacement
Background Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for symptomatic patients with aortic stenosis and elevated procedural risk. Many deaths following TAVR are because of noncardiac causes and comorbid disease burden may be a major determinant of postprocedure...
Main Authors: | Daniel R. Feldman, Mikhail D. Romashko, Benjamin Koethe, Sonika Patel, Hassan Rastegar, Yong Zhan, Charles D. Resor, Annie C. Connors, Carey Kimmelstiel, David Allen, Andrew R. Weintraub, Benjamin S. Wessler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.018978 |
Similar Items
-
Current Prostheses for Transcatheter Heart Valve Replacement: A Technical and Clinical Review
by: Piotr Nikodem Rudziński, et al.
Published: (2022-07-01) -
Valve-in-valve transcatheter mitral valve replacement procedure in prosthetic valve stenosis
by: Mridul Bansal, et al.
Published: (2023-07-01) -
Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?
by: Kyriakos Dimitriadis, et al.
Published: (2023-06-01) -
Sex difference and outcome trends following transcatheter aortic valve replacement
by: Gabby Elbaz-Greener, et al.
Published: (2022-10-01) -
Early Experience With Transcatheter Mitral Valve Replacement: A Systematic Review
by: David del Val, et al.
Published: (2019-09-01)